Common Contracts

SURGIQUEST, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT March 10, 2015

Rights Agreement • November 10th, 2015 • Surgiquest Inc • Surgical & medical instruments & apparatus • Delaware

• Contract Type
  Rights Agreement
• Filed
  November 10th, 2015
• Company
  Surgiquest Inc
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  Delaware

This Fourth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of the 10th day of March, 2015, by and among SurgiQuest, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock set forth on Exhibit A hereto (the “Series A Holders”), the holders of the Company’s Series B Preferred Stock set forth on Exhibit B hereto (the “Series B Holders”), the holders of the Company’s Series C Preferred Stock set forth on Exhibit C hereto (the “Series C Holders”), the holders of the Company’s Series D Preferred Stock set forth on Exhibit D hereto (the “Series D Holders”) and the purchasers of the Company’s Series E Preferred Stock set forth on Exhibit E hereto (the “Series E Purchasers” and together with the Series A Holders, the Series B Holders, the Series C Holders and the Series D Holders, the “Investors”).

SURGIQUEST, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT March 10, 2015

Rights Agreement • October 13th, 2015 • Surgiquest Inc • Surgical & medical instruments & apparatus • Delaware

• Contract Type
  Rights Agreement
• Filed
  October 13th, 2015
• Company
  Surgiquest Inc
• Industry
  Surgical & medical instruments & apparatus
• Jurisdiction
  Delaware

This Fourth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of the 10th day of March, 2015, by and among SurgiQuest, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock set forth on Exhibit A hereto (the “Series A Holders”), the holders of the Company’s Series B Preferred Stock set forth on Exhibit B hereto (the “Series B Holders”), the holders of the Company’s Series C Preferred Stock set forth on Exhibit C hereto (the “Series C Holders”), the holders of the Company’s Series D Preferred Stock set forth on Exhibit D hereto (the “Series D Holders”) and the purchasers of the Company’s Series E Preferred Stock set forth on Exhibit E hereto (the “Series E Purchasers” and together with the Series A Holders, the Series B Holders, the Series C Holders and the Series D Holders, the “Investors”).